Anal Dysplasia

11 registered clinical trials studyying Anal Dysplasia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV NCT06624839	University of Maryland, Baltimore	Phase 2
Active Not Recruiting	Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening NCT06971276	Massachusetts Eye and Ear Infirmary	—
Active Not Recruiting	Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL NCT05555862	Frantz Viral Therapeutics, LLC	Phase 2
Recruiting	Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. NCT03061435	Dr. Danielle Vicus	N/A
Withdrawn	PDT Plus Vitamin D3 for Anal Dysplasia NCT02698293	Abramson Cancer Center at Penn Medicine	Phase 1
Unknown	Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals NCT04099433	University of Roma La Sapienza	N/A
Completed	Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) NCT03100045	Johns Hopkins University	Phase 1
Terminated	The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men NCT02503111	University Health Network, Toronto	N/A
Withdrawn	Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV NCT01663558	United States Naval Medical Center, San Diego	Phase 4
Terminated	Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia NCT01384240	Anandasabapathy, Sharmila, M.D.	EARLY_Phase 1
Completed	Screening for HIV-Associated Anal Cancer NCT00188292	University Health Network, Toronto	—